For example, American, European, Japanese, and other drug regulators have developed guidelines, through the International Conference on Harmonization, that take advantage of their collective expertise. Countries such as South Korea and Singapore are drawing on these guidelines to flesh out their own regulatory systems.
同理，监管应该基于国际标准（只要有）。比如，美国、欧洲和日本及其他国的药品监管部门都根据国际协调会议（International Conference on Harmonization）依靠集体经验制定了指引。韩国和新加坡等国家正在制定类似指引充实监管体系。这些国家的公民因此能很快用上新药，它们的研究人员也更容易参与全球临床研究，这对于国内产业来说是一个福音。